Tower Research Capital (TRC)’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,872
| Closed | -$2.6K | – | 6345 |
|
|
2023
Q4 | $2.6K | Sell |
11,872
-68
| -0.6% | -$15 | ﹤0.01% | 5190 |
|
|
2023
Q3 | $3.76K | Buy |
11,940
+4,612
| +63% | +$1.45K | ﹤0.01% | 4957 |
|
|
2023
Q2 | $6.78K | Buy |
7,328
+2,695
| +58% | +$2.49K | ﹤0.01% | 4637 |
|
|
2023
Q1 | $4K | Buy |
4,633
+1,175
| +34% | +$1.01K | ﹤0.01% | 5142 |
|
|
2022
Q4 | $6K | Sell |
3,458
-1,791
| -34% | -$3.11K | ﹤0.01% | 4800 |
|
|
2022
Q3 | $11K | Buy |
5,249
+4,272
| +437% | +$8.95K | ﹤0.01% | 4490 |
|
|
2022
Q2 | $3K | Buy |
977
+837
| +598% | +$2.57K | ﹤0.01% | 5445 |
|
|
2022
Q1 | $1K | Buy |
+140
| New | +$1K | ﹤0.01% | 5921 |
|
|
2021
Q3 | – | Sell |
-2,035
| Closed | -$21K | – | 6317 |
|
|
2021
Q2 | $21K | Sell |
2,035
-86
| -4% | -$887 | ﹤0.01% | 3863 |
|
|
2021
Q1 | $16K | Sell |
2,121
-692
| -25% | -$5.22K | ﹤0.01% | 4075 |
|
|
2020
Q4 | $11K | Sell |
2,813
-3,864
| -58% | -$15.1K | ﹤0.01% | 4272 |
|
|
2020
Q3 | $24K | Buy |
6,677
+3,928
| +143% | +$14.1K | ﹤0.01% | 3808 |
|
|
2020
Q2 | $25K | Buy |
+2,749
| New | +$25K | ﹤0.01% | 3572 |
|